Benzonatate Capsule
Product Images NDC 51655-762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 51655-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 762 20 Master Bottle Label Approval Rev A 07 21)

Label (51655 762 20 Master Bottle Label Approval   Rev A 07 21)
This is a description of a medication called Benzonatate, which comes in capsule form in a package of 20. The dosage information is provided on the package insert, and the medication must be stored at a controlled room temperature between 20° and 25°C. The packaging also includes warnings to keep the medication out of the reach of children and to store it in the original container while protecting it from light. The medication was repackaged by Northwind Pharmaceuticals and has a GTIN of 0035165762202. The capsule contains Benzonatate, USP 200mg, and comes from Lot 0000000000 made by Epic Phamma, LLC. The S/N is 000000000000000, and there is no given expiration date.*
FDA Label Image

Structure Formula (Structure Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.